EU Proposes Changes To Labeling Of Investigational Drugs Under Clinical Trial Regulation
Executive Summary
The European Commission is inviting stakeholder feedback on proposals to do away with the need to display the expiry date on the primary packaging of investigational drugs in certain situations.
You may also be interested in...
EU Finalizes Option To Omit Expiry Date On Inner Labeling Of Investigational Drugs
Revised labeling requirements for unauthorized investigational and auxiliary medicinal products under the EU Clinical Trial Regulation have been published in the Official Journal.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.